Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the effects of a combined arm rotation and walking exercise regimen on glycemic control in type 2 diabetes, finding significant reductions in postprandial blood glucose and HbA1c levels.
Astaxanthin supplementation significantly reduced inflammation-related microRNAs and improved metabolic markers in type 2 diabetes patients.
This pilot study evaluated the Type 1 Diabetes and Life (T1DAL) intervention aimed at improving health-related quality of life in individuals with Type 1 diabetes.
This study evaluated the effectiveness of Cognitive Behavioral Therapy (CBT) for Type 2 diabetes patients with metabolic syndrome, showing significant improvements in depression and self-management behaviors.
This study compared closed-loop therapy with CSII + CGM in individuals with type 2 diabetes, finding that closed-loop therapy significantly improved glycemic control.
This study evaluated the impact of hybrid closed-loop insulin delivery on sleep in young people newly diagnosed with type 1 diabetes and their parents, finding no significant differences in sleep outcomes compared to standard care.
This study investigated the effects of cocoa supplementation on diabetic neuropathy in individuals with Type 2 Diabetes. Results indicated no significant differences between cocoa and placebo groups.
This study investigated the effects of coriander seed supplementation on glycemic indices and lipid profiles in patients with type 2 diabetes, finding significant reductions in several health markers.
This study investigated the impact of CPAP therapy on glycaemic control in patients with type 2 diabetes and obstructive sleep apnoea, finding no significant changes in most glucose metrics.
This study compared the effects of dapagliflozin and vitamin E in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes, finding significant improvements in several metabolic parameters with dapagliflozin.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
